Despite efforts have been made to reduce MYCN levels to improve prognosis across multiple cancer types, including pediatric brain tumors, further research is essential to refine therapeutic strategies and enhance survival outcomes in patients with MYCN-amplified tumors. Here, MYCN is linked to cancer.